As screening for breast cancer has become established in many European countries attention has become focused on those women who develop breast cancer within two years of a mammogram reported as normal. One recent study (British Journal of Cancer 1995;71:337-9) came from Florence, where between 1989 and 1992 a total of 134 women were found to have cancers after their mammograms two years earlier had been reported normal. Eighty five of these cancers were detected at the later routine mammogram; 49 were diagnosed because they caused symptoms -interval cancers.
Families with colorectal cancer
A family history of colorectal cancer is widely accepted as an indication for screening for the disease, and one unit offering this service is the Family Cancer Clinic at St Marks Hospital, London (Gut 1995; 36:385-90) . Since 1985 colonoscopy has been performed on 644 asymptomatic men and women from 436 families with a history of colorectal cancer. Seven cases of colorectal cancer were diagnosed at an average age of 49, and 144 persons werefound to have one or more adenomas. All the patients with a cancer had two or more generations of relatives affected by colorectal cancer or adenomas in their family. All but one of the carcinomas found were in individuals under the age of 60, and these were all in the proximal colon. These data support the view that colonoscopy is the preferred method of screening individuals with a high genetic risk. Further research will be needed, says the report, to confirm the strong predictive power of having two or more generations affected by cancer or adenomas.
Screening for cancer of the ovary
Screening for breast cancer is well established (at least for women over the age of 50), but the position is very different for ovarian cancer. A consensus conference organised by the United States National Institutes of Health was reported in the Journal of the American Medical Association in February (1995;273:491-7) . It concluded that no evidence was yet available to support general screening using either the serum tumour marker CA 125 or transvaginal ultrasound. 115 If the disease is assumed to have a prevalence of 50 cases per 100000 and a test has a 99% specificity and 100% sensitivity it would still yield only one woman with cancer in every 21 with a positive screen. At present women who are screen positive are referred for laparotomy or laparoscopy. The report cites one recent study using transvaginal ultrasound in which 61 operations detected five early ovarian cancers, three of which were of borderline histology. Screening would require a test with a specificity before surgery of 99% or better, and should only be undertaken as part of a randomised controlled trial.
The lifetime risk of ovarian cancer for women with no family history is one in 70; those with one first degree relative with the disease have a risk of one in 20. Even for women with a family history, says the report, the drawbacks of screening may exceed the benefits. What it recommends is that women with a family history should be encouraged to participate in randomised clinical trials of screening.
Papilloma virus and cervical cancer
Infection of the cervix with human papilloma virus (HPV), especially HPV types 16 and 18, is known to increase the risk of cervical cancer. The Canadian Task Force on the Periodic Health Examination has recently reviewed the resultsofscreening for this infection (Canadian Medical Association Journal 1995; 152:483-93) . Its conclusion is that screeningfor the virus should not be added to routine cervical screening. Most women with papillomavirus infection are unaware of it, and the diagnosis may produce a significant labelling effect. "Given the prevailing state ofimprecisediagnostic testing for HPV infection, the uninterpretable risk ofsubsequent morbidity, and the general ineffectiveness of treatment of HPV infection ", says the report, "screeningfor HPV should be excluded from the routine periodic health examination of asymptomatic women ".
Screening-induced epidemic
In 1994 cancer of the prostate became the most commonly diagnosed non-skin cancer in men in the United States, with an estimated 200 000 new cases. A report in the Journal of the American Medical Association (1995; 273:548-52) states that between 1989 and 1991 the incidence of the cancer rose by 40%. This dramatic increase appears to be due to the use of new screening tests to detect symptomless small cancers.
Measurement of the serum concentration of prostate specific antigen has become commonplace in men over the age of 65: the numbers tested have risen from 1430 per 100000 men in 1988 to 18000 per 100000 in 1991. Transrectal ultrasound tests have increased eightfold in the same time period. Abnormal test results are followed by needle biopsy of the prostate, and virtually all the increase in the numbers of men found to have prostatic cancer is accounted for by needle biopsy identification of localised disease.
Public awareness of prostatic cancer has also increased in the United States, and several medical societies are pressing for early identification of the disease and aggressive treatment. Yet, says the JAMA article, "are we simply uncovering a large pool of latent disease that does not pose a threat to public health?" At present there is no convincing evidence that mass screening using these methods has any effect on mortality from the disease.
Dislike of stools
Large scale studies have shown that screening for colorectal cancer by tests on the faeces for occult blood commonly yield unacceptably high numbers of false positive results, and the uptake of the tests is usually poor in the general population.
A study in Market Harborough, a town of25000 inhabitants almost all served by a single largegroup practice, has highlighted some of the reasons for people refusing the test Oournal of Epidemiology and Community Health 1995; 49:84-6) . Of 4000 men and women offered the test, fewer than half took up the offer. From the 2611 refusers 351 wrote declining the test, and a sample of 81 of these were interviewed. Thirty said stool collection was unpleasant; 25 said they were ill; 18 were afraid offurther tests and surgery; and 21 said they felt perfectly well and didn't think they needed testing.
This study confirms others in finding a substantial fraction of people who refused screening because they felt well and did not therefore see any need to be tested. Other reasons givenbeing unwell and disliking the collection of stool specimens -are unlikely to be real, says the report, which suggests that these excusesmay mask fears about cancer. W'hatever the explanation, screeningfor colorectal cancer by occult blood tests seems doomed in Britain unless health education can change attitudes substantially.
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Testing rnobflity Screening usually means detecting occult disease, but it may also be used to identify a group of people who may benefit from non-specific treatment. The National Institute on Ageing in the United States has recently completed a project on the mobility of the elderly. People aged 65 living in small towns in Iowa were recruited in the early 1980s, and at their sixth annual follow up 1122 of them who reponed they were free from disability had their leg function assessed (New England Journal of Medicine 1995; 332:556-61) .
The tests included standing balance, walking speed, and ability (repeated five times) to rise from a chair, and on each test the subjects were scored from 0 to 4. They were then followed up for four years. At the end of that time lower scores on the baseline performance were associated with an increase in the frequency of disability in the activities of daily living. Measures of this kind may, says the rep on, be used to identify those elderly people most likely to benefit from preventive treatments to improve muscle strength, gait, and balance.
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